These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 33217824)
21. Identification and development of an independent immune-related genes prognostic model for breast cancer. Chen L; Dong Y; Pan Y; Zhang Y; Liu P; Wang J; Chen C; Lu J; Yu Y; Deng R BMC Cancer; 2021 Mar; 21(1):329. PubMed ID: 33785008 [TBL] [Abstract][Full Text] [Related]
22. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
23. A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade. Hermanns T; Savio AJ; Olkhov-Mitsel E; Mari A; Wettstein MS; Saba K; Bhindi B; Kuk C; Poyet C; Wild PJ; Noon A; Bashir S; Juvet T; Rendon RA; Waltregny D; van der Kwast T; Finelli A; Kulkarni GS; Fleshner NE; Lo K; Bapat B; Zlotta AR Urol Oncol; 2020 Jun; 38(6):603.e1-603.e7. PubMed ID: 32081560 [TBL] [Abstract][Full Text] [Related]
24. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder. Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478 [TBL] [Abstract][Full Text] [Related]
25. Identifying Potential Prognostic Markers for Muscle-Invasive Bladder Urothelial Carcinoma by Weighted Gene Co-Expression Network Analysis. Feng Y; Jiang Y; Wen T; Meng F; Shu X Pathol Oncol Res; 2020 Apr; 26(2):1063-1072. PubMed ID: 31011911 [TBL] [Abstract][Full Text] [Related]
26. A zinc finger protein gene signature enables bladder cancer treatment stratification. Zhang J; Zhang C; Cao P; Zheng X; Yu B; Cao H; Gao Z; Zhang F; Wu J; Cao H; Hao C; Sun Z; Wang W Aging (Albany NY); 2021 May; 13(9):13023-13038. PubMed ID: 33962398 [TBL] [Abstract][Full Text] [Related]
27. A predictive nomogram for individualized recurrence stratification of bladder cancer using multiparametric MRI and clinical risk factors. Xu X; Wang H; Du P; Zhang F; Li S; Zhang Z; Yuan J; Liang Z; Zhang X; Guo Y; Liu Y; Lu H J Magn Reson Imaging; 2019 Dec; 50(6):1893-1904. PubMed ID: 30980695 [TBL] [Abstract][Full Text] [Related]
28. Identification of a nine-gene panel as a prognostic indicator for recurrence with muscle-invasive bladder cancer. Han Y; Zheng Q; Tian Y; Ji Z; Ye H J Surg Oncol; 2019 Jun; 119(8):1145-1154. PubMed ID: 30887516 [TBL] [Abstract][Full Text] [Related]
29. The role of oncostatin M receptor gene polymorphisms in bladder cancer. Deng S; He SY; Zhao P; Zhang P World J Surg Oncol; 2019 Feb; 17(1):30. PubMed ID: 30755233 [TBL] [Abstract][Full Text] [Related]
30. Rac Family Small GTPase 3 Correlates with Progression and Poor Prognosis in Bladder Cancer. Zheng W; Zhang J; Song Q; Xu Y; Zhu M; Ma J DNA Cell Biol; 2021 Mar; 40(3):469-481. PubMed ID: 33600260 [TBL] [Abstract][Full Text] [Related]
31. Identification of a three-gene expression signature of early recurrence in non-muscle-invasive urothelial cell carcinoma of the bladder. Dubosq F; Ploussard G; Soliman H; Turpin E; Latil A; Desgrandchamps F; de The H; Mongiat-Artus P Urol Oncol; 2012; 30(6):833-40. PubMed ID: 21489836 [TBL] [Abstract][Full Text] [Related]
32. Identifying stage-associated hub genes in bladder cancer via weighted gene co-expression network and robust rank aggregation analyses. Feng F; Zhong YX; Huang JH; Lin FX; Zhao PP; Mai Y; Wei W; Zhu HC; Xu ZP Medicine (Baltimore); 2022 Dec; 101(51):e32318. PubMed ID: 36595851 [TBL] [Abstract][Full Text] [Related]
33. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631 [TBL] [Abstract][Full Text] [Related]
34. Decreased expression of KAI1 metastasis suppressor gene is a recurrence predictor in primary pTa and pT1 urothelial bladder carcinoma. Su JS; Arima K; Hasegawa M; Franco OE; Umeda Y; Yanagawa M; Sugimura Y; Kawamura J Int J Urol; 2004 Feb; 11(2):74-82. PubMed ID: 14706010 [TBL] [Abstract][Full Text] [Related]
35. Identification of biomarkers associated with progression and prognosis in bladder cancer via co-expression analysis. Shi S; Tian B Cancer Biomark; 2019; 24(2):183-193. PubMed ID: 30689556 [TBL] [Abstract][Full Text] [Related]
36. Novel nomograms to predict recurrence and progression in primary non-muscle-invasive bladder cancer: validation of predictive efficacy in comparison with European Organization of Research and Treatment of Cancer scoring system. Kim HS; Jeong CW; Kwak C; Kim HH; Ku JH World J Urol; 2019 Sep; 37(9):1867-1877. PubMed ID: 30535715 [TBL] [Abstract][Full Text] [Related]
37. An immune-related prognostic signature for predicting breast cancer recurrence. Tian Z; Tang J; Liao X; Yang Q; Wu Y; Wu G Cancer Med; 2020 Oct; 9(20):7672-7685. PubMed ID: 32841536 [TBL] [Abstract][Full Text] [Related]
38. Oncogene miR-187-5p is associated with cellular proliferation, migration, invasion, apoptosis and an increased risk of recurrence in bladder cancer. Li Z; Lin C; Zhao L; Zhou L; Pan X; Quan J; Peng X; Li W; Li H; Xu J; Xu W; Guan X; Chen Y; Lai Y Biomed Pharmacother; 2018 Sep; 105():461-469. PubMed ID: 29883941 [TBL] [Abstract][Full Text] [Related]
39. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients. Ankney JA; Xie L; Wrobel JA; Wang L; Chen X BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747 [TBL] [Abstract][Full Text] [Related]
40. INHBA is a prognostic predictor for patients with colon adenocarcinoma. Li X; Yu W; Liang C; Xu Y; Zhang M; Ding X; Cai X BMC Cancer; 2020 Apr; 20(1):305. PubMed ID: 32293338 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]